PSC phenotype or care pathway? Interpreting PSC with and without IBD
Digestive and Liver Disease · 2026-08 · 58 (8) · 1101-1102
DOI: 10.1016/j.dld.2026.05.003 ↗Kurz gefasst
Leserbrief in der Zeitschrift Digestive and Liver Disease, 2026-08. Verfasst von Xichen Fan und 1 weiteren Autor:innen. Beteiligte Einrichtung: China Medical University, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We read with great interest the national multicenter cohort study by Theodoros and colleagues describing current characteristics of primary sclerosing cholangitis (PSC) with or without inflammatory bowel disease (IBD) in Greece [1]. The study is valuable because contemporary PSC data from southern Europe remain limited and the comparison of PSC-IBD with PSC-only is clinically relevant. The key issue, however, is whether this study compared PSC phenotypes, or the care pathways through which PSC with and without IBD came to clinical attention.
Autor:innen und Institutionen
- China Medical University, China.
- Department of Radiotherapy, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, China. Electronic address: zhanggong7446@sxmu.edu.cn.
Zitieren
APA
Fan, X., & Zhang, G. (2026). PSC phenotype or care pathway? Interpreting PSC with and without IBD. Digestive and Liver Disease, 58(8), 1101-1102. https://doi.org/10.1016/j.dld.2026.05.003
Vancouver
Fan X, Zhang G. PSC phenotype or care pathway? Interpreting PSC with and without IBD. Digestive and Liver Disease. 2026;58(8):1101-1102. doi:10.1016/j.dld.2026.05.003
BibTeX
@article{Fan2026,
author = {Fan, Xichen and Zhang, Gong},
title = {PSC phenotype or care pathway? Interpreting PSC with and without IBD},
journal = {Digestive and Liver Disease},
year = {2026},
volume = {58},
number = {8},
pages = {1101--1102},
doi = {10.1016/j.dld.2026.05.003}
}
EUVIMED